The combination indexes for these combinations were lower than 1 in both 253J and T24 cells (Figure 2B), indicating that the combination of evodiamine and TRAIL synergistically decreases the survival of bladder cancer cells. The gene discussed is TNFSF10; the disease is urinary bladder carcinoma.